Emergency Departments in hospitals should always keep first-aid equipment handy as a critical case with any kind of diagnosis might land up at the ED at any given point of time.
Obsessive-compulsive disorder (OCD) patients are now offered with a new treatment option as the FDA grants de novo approval for Brainsway’s deep transcranial magnetic stimulation (TMS) system.
A new biomarker might possibly furnish new clues required to develop a diagnostic tool for hypoglycemia-associated autonomic failure (HAAF), an LSU Pennington Biomedical Research Center study found. There is no current objective diagnostic device for this life-threatening condition, if unchecked.
Renowned cardiologists feel that children fixed with epicardial pacemakers may incur coronary artery compression a little more frequently than earlier thought. A review of patient records at Boston Children's Hospital led to the suggestion of stringent scrutinizing to diagnose children in danger of developing complications.
Kindbody, a women-empowered startup was launched on Tuesday by Gina Bartasi, Progyny founder and other women leaders, remarkably co-founders Fahimeh Sasan, MD, from Mount Sinai, and Joanne Schneider, former product leader at Google and Flatiron Health, and Cynthia Hudson, clinical embryology and IVF expert and owner of Manhattan Fertility Specialists.
Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
A pivotal clinical study in the U.S. on the Tendyne Transcatheter Mitral Valve Replacement (TMVR) system for treating mitral regurgitation has been commenced by Abbott.
The San Diego-based company NuVasive has announced US-FDA 510(k) clearance for its Pulse spinal surgical automation platform. The platform includes 2D and 3D navigation and smart imaging capabilities, with implemented surgical planning, neuromonitoring, patient-specific rod bending tech and radiation reduction.
Healthy.io, of Israel, gains FDA 510(k) approval for Dip.io, it's domestic urinalysis kit that transforms a smartphone into a clinical-standard diagnostic machine. It is the first and only smartphone-based urine analysis to be cleared as a Class 2 device.
A research team at the Imperial College London have developed a new sensor-based device to display fetal movements and growth in high-risk pregnancies. This is an alternative to the current self-reporting system where the mothers notice changes in fetus movements and seek medical help if needed.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.